A low critical path delay structure for composite field AES S-box based on constant matrices multiplication merging
IEICE ELECTRONICS EXPRESS
Authors: Zhang, Xiaoqiang; Zhang, Xinggan; Tang, Lan; Zheng, Xinxing; Ni, Tianming; Wu, Ning
Abstract
In this paper, a low critical path delay (CPD) circuit structure is proposed for composite field S-box circuit. In the low CPD structure, multiplicative inverse over GF(2(4)) and multiplicative over GF(2(4)) are constructed by AND-XOR-networks. The XOR-networks in the last two multiplications over GF(2(4)) are further merged with the following constant matrix multiplication operation to shorten the CPD. Finally, hardware complexities of our designs are compared with previous works. The comparisons indicate that our proposed method is effective. Our design of S-box/InvS-box based on the proposed method has lower CPD.
Retinitis pigmentosa and renal failure in a patient with mutations in INVS
NEPHROLOGY DIALYSIS TRANSPLANTATION
Authors: O'Toole, John F.; Otto, Edgar A.; Frishberg, Yaacov; Hildebrandt, Friedhelm
Abstract
Background. Nephronophthisis (NPHP) is an autosomal recessive disease, which is the most common genetic cause of end-stage renal disease in the first three decades of life. The disease is caused by mutations in the NPHP 1-5 genes, and is referred to as NPHP types 1-5, respectively. The association of NPHP and retinitis pigmentosa (RP) is known as Senior-Loken syndrome (SLS). The RP is associated with 10% of cases of NPHP types 1, 3 and 4, and all cases of NPHP type 5, but never in NPHP type 2, the infantile form of NPHP. The NPHP type 2 is distinguished from other types of NPHP by its early age of onset and by cystic enlargement of the kidneys. Methods. Mutational analysis of all five NPHP genes was performed by exon sequencing in a child with infantile NPHP and RP from a consanguineous kindred. Results. A homozygous mutation was identified in exon 13 of inversin (INVS) (C2719T, R907X) in this child. Conclusions. This is the first report of the presence of RP in a patient with NPHP type 2 and INVS mutations. This report now extends the association of RP with NPHP to NPHP type 2.